PD
WGS icon

Point72 (DIFC)’s GeneDx Holdings WGS Stock Holding History

Point72 (DIFC)’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,375
Closed -$122K – 2146
2025
Q1 		$122K Buy
+1,375
New +$119K 0.01% 1028
2024
Q4 		– Sell
-5,192
Closed -$220K – 1946
2024
Q3 		$220K Buy
+5,192
New +$175K 0.01% 834

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Point72 (DIFC)'s WGS Position: Q2 2025 in Review

Point72 (DIFC) sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 1,375 shares — an estimated $122K sold.

Point72 (DIFC) first reported a position in WGS in Q3 2024 and held it in 2 quarters. The position peaked at $220K in Q3 2024. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

  • Point72 (DIFC) reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 1,375 GeneDx Holdings shares in Q2 2025, an estimated $122K.
  • Point72 (DIFC) first reported a position in GeneDx Holdings in Q3 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s GeneDx Holdings position peaked at $220K in Q3 2024.
  • 231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.